Increase of infectious complications in ABO-incompatible kidney transplant recipients-a single centre experience

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 4124-4131

  Habicht, Antje ^a   Bröker, Verena ^a   Blume, Cornelia ^a   Lorenzen, Johan ^a   Schiffer, Mario ^a   Richter, Nikolaus ^a   Klempnauer, Juergen ^a   Haller, Hermann ^a   Lehner, Frank ^a   Schwarz, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ABO incompatible; infectious complication; renal transplantation

Indexed keywords

BASILIXIMAB; COTRIMOXAZOLE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VALGANCICLOVIR;

ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DESENSITIZATION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOADSORPTION; INFECTION COMPLICATION; INFECTION RISK; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; OBESITY; OUTCOME ASSESSMENT; PNEUMONIA; POLYOMA VIRUS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SURVIVAL RATE; URETER OBSTRUCTION; UROSEPSIS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WOUND HEALING IMPAIRMENT;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INFECTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 80755180378     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr215     Document Type: Article

References (49)

1. Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibodymediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007; 11: 128-141 (Pubitemid 47012508)
2. Ishida H, Miyamoto N, Shirakawa H et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007; 7: 825-831 (Pubitemid 46481177)
3. Gloor JM, Lager DJ, Fidler ME et al. A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80: 1572-1577 (Pubitemid 43005868)
4. Sonnenday CJ, Warren DS, Cooper M et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315-1322 (Pubitemid 39013579)
5. Segev DL, Simpkins CE, Warren DS et al. ABO incompatible hightiter renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570-2575
6. Montgomery RA, Locke JE. ABO-incompatible transplantation: less may be more. Transplantation 2007; 84 (12 Suppl): S8-S9
7. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730-731 (Pubitemid 37072012)
8. Rydberg L, Bengtsson A, Samuelsson O et al. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005; 17: 666-672 (Pubitemid 40558223)
9. Kumlien G, Ullstrom L, Losvall A et al. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568-1575 (Pubitemid 44326333)
10. Tyden G, Donauer J, Wadstrom J et al. Implementation of a Protocol for ABO-incompatible kidney transplantation-a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-1155 (Pubitemid 46743673)
11. Genberg H, Kumlien G, Wennberg L et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85: 1745-1754
12. Ahlenstiel T, Offner G, Strehlau J et al. ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B. Xenotransplantation 2006; 13: 141-147
13. Donauer J, Wilpert J, Geyer M et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplantation 2006; 13: 108-110
14. Norden G, Briggs D, Cockwell P et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006; 13: 148-153
15. Oettl T, Halter J, Bachmann A et al. ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant 2009; 24: 298-303
16. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760 (Pubitemid 351347767)
17. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526 (Pubitemid 46376465)
18. Mengel M, Bogers J, Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5: 1050-1056 (Pubitemid 40571253)
19. Wilpert J, Geyer M, Pisarski P et al. On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2007; 22: 3048-3051 (Pubitemid 350093468)
20. Hernandez D, Rufino M, Armas S et al. Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era. Nephrol Dial Transplant 2006; 21: 2908-2915 (Pubitemid 44542249)
21. Tyden G, Kumlien G, Genberg H et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145-148 (Pubitemid 40095139)
22. Tyden G, Kumlien G, Genberg H et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 2006; 13: 105-107
23. Haidinger M, Schmaldienst S, Kormoczi G et al. Vienna experience of ABO-incompatible living-donor kidney transplantation. Wien Klin Wochenschr 2009; 121: 247-255
24. Geyer M, Fischer KG, Drognitz O et al. ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab-insights and uncertainties. Contrib Nephrol 2009; 162: 47-60
25. Wilpert J, Fischer KG, Pisarski P et al. Long-term outcome of ABOincompatible living donor kidney transplantation based on antigenspecific desensitization. An observational comparative analysis. Nephrol Dial Transplant 2010; 25: 3778-3786
26. Lopau K, Syamken K, Rubenwolf P et al. Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation. Kidney Blood Press Res 2010; 33: 52-59
27. Berger PM, Diamond JR. Ureteral obstruction as a complication of renal transplantation: a review. J Nephrol 1998; 11: 20-23 (Pubitemid 28162360)
28. Karam G, Hetet JF, Maillet F et al. Late ureteral stenosis following renal transplantation: risk factors and impact on patient and graft survival. Am J Transplant 2006; 6: 352-356 (Pubitemid 43382171)
29. Mateo R, Vivas C, Shapiro R et al. Cytomegalovirus infection of the native ureter after liver-kidney transplantation. Urology 1999; 54: 366
30. Peretti N, Said MH, Bouvier R et al. Cytomegalovirus infection may cause ureteral necrosis. Transplantation 2000; 69: 670-671 (Pubitemid 30129607)
31. Thomas MC, Russ GR, Mathew TH et al. Four cases of CMV ureteritis: emergence of a new pattern of disease? Clin Transplant 2001; 15: 354-358
32. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109 (Pubitemid 29061146)
33. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354-360 (Pubitemid 41022114)
34. Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirusassociated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286 (Pubitemid 40734783)
35. Fishman JA. BK virus nephropathy-polyomavirus adding insult to injury. N Engl J Med 2002; 347: 527-530 (Pubitemid 34879342)
36. Mylonakis E, Goes N, Rubin RH et al. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 2001; 72: 1587-1592 (Pubitemid 33096728)
37. Mengel M, Marwedel M, Radermacher J et al. Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190-1196 (Pubitemid 36722523)
38. Binet I, Nickeleit V, Hirsch HH et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-922 (Pubitemid 29169141)
39. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-496 (Pubitemid 34879336)
40. Cooper N, Arnold DM. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol 2010; 149: 3-13
41. Sidner RA, Book BK, Agarwal A et al. In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody. Hum Antibodies 2004; 13: 55-62 (Pubitemid 40164116)
42. Aksoy S, Harputluoglu H, Kilickap S et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 2007; 48: 1307-1312 (Pubitemid 47079357)
43. Grim SA, Pham T, Thielke J et al. Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant 2007; 21: 628-632 (Pubitemid 47399427)
44. Kamar N, Milioto O, Puissant-Lubrano B et al. Incidence and predictive factors for infectious disease after rituximab therapy in kidneytransplant patients. Am J Transplant 2010; 10: 89-98
45. Tydén G, Genberg H, Tollemar J et al. A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation. Transplantation 2009; 87: 1325-1329
46. Moreso F, Seron D, Morales JM et al. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. Clin Transplant 1998; 12: 198-205 (Pubitemid 28269241)
47. Trofe J, Cavallo T, First MR et al. Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc 2002; 34: 1788-1789
48. Gloor JM, Lager DJ, Moore SB et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971-977 (Pubitemid 36438524)
49. Takahashi K, Saito K, Takahara S et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096 (Pubitemid 38868599)